Surgery Partners, Inc. is a healthcare services company that owns and operates a national network of surgical facilities and ancillary services in the United States. The company operates ambulatory surgery centers, short-stay surgical hospitals, multi-specialty physician practices, and anesthesia services. Its facilities primarily provide non-emergency surgical procedures across specialties including orthopedics, pain management, ophthalmology, gastroenterology, and general surgery. Surgery Partners serves patients and physicians through a model that includes partnerships with physician groups and health care systems, often holding majority ownership or providing management services. The company operates in 30 states and relies on reimbursement from private insurance, government programs such as Medicare and Medicaid, and self-pay patients. Founded in 2004, the company has expanded through mergers with NovaMed, Symbion, and National Surgical Healthcare.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Care Facilities Homepage surgerypartners.com
Sector Healthcare IR page ir.surgerypartners.com
Tags
ambulatory surgery centers, surgical hospitals, anesthesia services, physician practices, orthopedics, ophthalmology, gastroenterology, general surgery, pain management, outpatient care, NovaMed, Symbion, National Surgical Healthcare
Press page —

Metrics

Valuation  
Market cap $ 1.815B
Market cap (USD) $ 1.815B
P/E -20.70
PEG —
P/BV 1.09
P/S 0.54
P/OCF 6.53
P/FCF 8.95
Dividend yield —
Turnover / mcap —
Returns  
ROE -4.4%
ROI -1.4%
ROIC 5.9%
Profit margin -2.4%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 223.9%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 34
Quality score 11.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
Revenue 3.309B 3.114B 2.743B 2.539B 2.225B 1.86B 1.831B 1.771B — 1.145B 959.891M 403.289M
Net profit -77.9M -168.1M -11.9M -54.6M -70.9M -116.1M -74.8M -205.706M — 9.453M 1.429M -65.897M
Free cash flow 195.6M 209.7M 205M 78.2M 29.5M 204M 55.9M 104.795M — 86.13M 51.042M 14.213M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
Share price 15.45 21.17 31.99 27.86 53.41 29.01 15.65 9.79 12.1 15.85 20.49 —
Price performance 12m -0.27 -0.34 0.15 -0.48 0.84 0.85 0.6 -0.19 -0.24 -0.23 — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 221M 288M 308M 327M 382M 430M 456M 496M 579M 602M
↳ YoY growth +24.1% +30.6% +6.8% +6.3% +16.9% +12.6% +6.1% +8.8% +16.7% +4.0%
↳ 5y CAGR +17.7% +16.5% +14.3% +9.6% +10.0% +12.1% +9.5%
Borrowings, current (USD) 27.8M 58.7M 55.6M 56M 64.4M 60.4M 62.8M 73.3M 101M 99.3M
Borrowings, non-current (USD) 1.41B 2.13B 2.27B 2.52B 2.79B 2.88B 2.56B 2.7B 3.27B 3.6B
Lease liabilities (USD) — 6.26M 57.2M 574M 621M 720M 894M 980M 1.13B 1.26B
Cash and deposits (USD) 69.7M 175M 184M 92.7M 318M 390M 283M 196M 270M 240M
Intangible assets (USD) 48M 58.9M 54.3M 47.3M 46.9M 43.7M 42.3M 54.8M 45.7M 41M
Right-of-use assets (USD) — — 0.00 298M 310M 324M 279M 255M 296M 289M
Net debt (borrowings + leases - cash) (USD) 1.37B 2.01B 2.2B 3.06B 3.16B 3.27B 3.23B 3.56B 4.23B 4.72B
Cash flow detail
Operating cash flow (USD) 125M — 145M 130M 247M 87.1M 159M 294M 300M 274M
Purchases of property, plant and equipment (USD) -39.1M — -39.8M -73.6M -42.9M -57.6M -80.6M -88.8M -90.4M -78.7M
Change in receivables (cash effect) (USD) -60.6M — -22.8M -23.5M -46.6M -32.1M -35.3M -47.2M -72.1M -53.8M
Share buybacks (cash effect) (USD) 0.00 — -1.98M 0.00 0.00 — — — — —
Interest paid (cash effect) (USD) -79.3M — -145M -180M -204M -194M -219M -170M -200M -257M
Income taxes paid (cash effect) (USD) -661,000 — -2.23M -1.6M -1.7M -1.5M -1.8M -1.4M -1.6M -1.2M
Share-based compensation (USD) 2.02M — 9.34M 10.2M 13.2M 17.4M 18.4M 17.7M 33.3M 14.8M
Operating cash flow before change in receivables (USD) 186M — 167M 153M 294M 119M 194M 341M 372M 328M
Free cash flow (OCF - PPE - intangibles) (USD) 86.1M — 105M 55.9M 204M 29.5M 78.2M 205M 210M 196M
Income detail
Total comprehensive income (USD) 85.1M — -118M 16.8M -9M 100M 195M 117M -40.2M 80.3M
Comprehensive income to owners (USD) 9.45M — -228M -103M -126M -41.4M 53.1M -30.6M -221M -96.5M
Provision for credit losses (USD) 24.2M — 0.00 0.00 — — — — — —
Credit cost ratio (credit losses / average receivables) (%) 12.2% — 0.0% 0.0% — — — — — —
Reported Mar 10, 2017 May 10, 2018 May 10, 2019 Mar 13, 2020 Mar 10, 2021 Mar 1, 2022 Mar 1, 2023 Feb 26, 2024 Mar 7, 2025 Mar 2, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

BRENTWOOD, Tenn., November 18, 2026 – Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), has amended its previously announced solicitation of consents (the “Consent Solicitation”) from holders (“Holders”) of its outstanding $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos. 86881W AF9 / U86786 AD9 / U86786 AE7; ISINs US86881WAF95 / USU86786AD98 / USU86786AE71) (the “Notes”) to certain proposed amendments (the “Proposed Amendments”) to the indenture governing the Notes, dated as of April 10, 2024 (as supplemented, the “Indenture”), among the Issuer, the guarantors party thereto and Wilmington Trust, National Association, as trustee (the “Trustee”), to increase the consent fee payable to Holders who validly deliver (and do not validly revoke) consents prior to the Expiration Time (as defined below) from $2.50 to $5.00 per $1,000 in principal amount of Notes (the “Increased Consent Fee”).

BRENTWOOD, Tenn., November 16, 2026 – Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), has commenced a solicitation of consents (the “Consent Solicitation”) from holders (“Holders”) of its outstanding $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos. 86881W AF9 / U86786 AD9 / U86786 AE7; ISINs US86881WAF95 / USU86786AD98 / USU86786AE71) (the “Notes”) to certain proposed amendments (the “Proposed Amendments”) to the indenture governing the Notes, dated as of April 10, 2024 (as supplemented, the “Indenture”), among the Issuer, the guarantors party thereto and Wilmington Trust, National Association, as trustee (the “Trustee”).

As previously announced, on October 23, 2026, Surgery Partners entered into an Agreement and Plan of Merger (as amended by Amendment No.

SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS Bull 7 Bear 0 Takeover offer

BRENTWOOD, Tenn., November 9, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2026.

Third Quarter 2026 Financial Highlights

(All comparisons are year-over-year unless otherwise noted; results reflect the ownership of the Idaho Falls facilities through September 13, 2026)

•Revenue decreased (0.8)% for the third quarter

◦Same-facility revenues increased 6.0% for the third quarter

◦Same-facility cases increased 0.2% for the third quarter

•Net loss attributable to Surgery Partners, Inc. was $21.1 million for the third quarter

◦Adjusted EBITDA was $132.7 million for the third quarter

Eric Evans, Chief Executive Officer, stated, “Our financial results in the third quarter reflect the impact of the successful Idaho Falls divestiture and sustained momentum in our core business, underscoring the value of our short-stay surgical platform.

Prompts

Surgery Partners, Inc. (ticker SGRY), listed in United States.

ETFs Holding Surgery Partners, Inc.

ETF Weight in ETF Shares Market value As of
SMIZ 0.54% 107,601 $ 1.495M Aug 31, 2026
IVSS 0.30% 4,803 $ 80.69K Jun 30, 2026
DFSV 0.23% 2,366,642 $ 62.905M Nov 12, 2026
GVLU 0.16% 15,617 $ 418.379K Nov 17, 2026
PSC 0.11% 147,562 $ 2.479M Jun 30, 2026
DFAT 0.10% 1,233,035 $ 32.774M Nov 12, 2026
FSYD 0.10% 10,285 $ 142.859K Aug 31, 2026
DFAS 0.07% 848,540 $ 22.554M Nov 12, 2026
DXUV 0.01% 21,047 $ 559.429K Nov 12, 2026
DFAC 0.01% 284,313 $ 7.557M Nov 12, 2026
DCOR 0.00% 68,076 $ 1.809M Nov 12, 2026
DFAU 0.00% 9,413 $ 250.198K Nov 12, 2026
DFUS 0.00% 9,294 $ 247.035K Nov 12, 2026
EBI 0.00% 257 $ 3,569.73 Aug 31, 2026
DFUV 0.00% 504 $ 13.396K Nov 12, 2026